Manipulation of Hydrocortisone Tablets Leads to Iatrogenic Cushing Syndrome in a 6-Year-Old Girl With CAH

Currently there are no commercially available hydrocortisone formulations for the treatment of children with congenital adrenal hyperplasia (CAH) that allow for smaller doses (0.1-1.25 mg) and incremental adjustments needed to control excess androgen production and avoid the negative effects of over...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Rayess, Heba, Fleissner, Kristin, Jaber, Mu’taz, Brundage, Richard C, Sarafoglou, Kyriakie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417883/
https://www.ncbi.nlm.nih.gov/pubmed/32803093
http://dx.doi.org/10.1210/jendso/bvaa091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417883/
https://www.ncbi.nlm.nih.gov/pubmed/32803093
http://dx.doi.org/10.1210/jendso/bvaa091

Ejemplares similares